Menard Chrystal

Avg. Two Year Performance

No purchase track record
< 1% Avg. Sale Return
0% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)(2%)(2%)< 1%< 1%
Sale Success Rate3 of 103 of 103 of 102 of 102 of 10
Drugs » Biotechnology

Chief Legal Officer:

Holdings: 105.85K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($252.06K) Net Amount
Buy:0--
Sell:($252.06K)$6.38 - $8.00